Curve logo

Curve Review

7.2
★★★★☆3.6/5
Website is offline and not taking patients

Curve scores highest on state availability and ease of access.

Curve: Website is offline and not taking patients. We're not linking to it. Here are the top-rated GLP-1 providers we recommend instead.

See our top-rated GLP-1 providers →
Compare top-rated alternatives ↓

Curve (Try Curve LLC) was a telehealth platform that sold compounded semaglutide and tirzepatide at a flat price across doses. Its website is now offline: the address no longer loads, so there is no way to sign up, refill or check current prices.

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
Website offlineNot taking patients

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

Vetted alternatives to Curve

6.4/ 10
Verified partner

Direct Meds

Best for: listed for disclosure only — see its FDA warning and BBB complaints first

★★★☆☆3.2/5

Editorial score · methodology

$249/mosemaglutide
$299/motirzepatide
CompoundedSemaglutideTirzepatideNAD+SermorelinLegitScript VerifiedFDA Warning
Get StartedRead full Direct Meds review →
7.6/ 10
Verified partner

Maximus

Best for: men seeking compounded GLP-1 alongside testosterone optimization

★★★★☆3.8/5

Editorial score · methodology

$250/mosemaglutide
$360/motirzepatide
CompoundedSemaglutideTirzepatideOrforglipronSermorelinFDA Warning
Get StartedRead full Maximus review →
8.0/ 10
Verified partner

Sesame Care

Best for: Brand-name GLP-1s at cash prices, no compounding

★★★★☆4/5

Editorial score · methodology

$149/mosemaglutide
CompoundedSemaglutideTirzepatideOrforglipron
Get StartedRead full Sesame Care review →
Curve logo
3.6 / 5
Our editorial rating

Curve at a glance

Type
GLP-1 telehealth provider
Availability
All 50 states
FDA status
No FDA warning letter on record

How we scored Curve

Each dimension is scored algorithmically from Curve’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.

Value25%

6.8/10

Curve no longer sells GLP-1 treatment, so no current price applies.

Effectiveness25%

6.2/10

Curve's offering is not built around the GLP-1 molecules with the strongest weight-loss trial evidence — weigh the clinical support carefully.

User Experience15%

7.6/10

Online intake and platform experience; 2 platform features disclosed.

Trust & Safety15%

8.5/10

Key details fully confirmed by our editors; no FDA warning letters on file.

Accessibility10%

9.0/10

Curve treats patients in all 50 states.

Support10%

6.6/10

Curve provides standard clinician follow-up; no extended coaching or community program is disclosed.

6scored dimensions
635providers compared

Each checked against the provider’s own site.

Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%

Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →

How we verified this Curve review

Last checked October 2026
  • Confirmed availability in all 50 states
  • Checked the FDA warning-letter database for enforcement actions

Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: high.

What we checked

FDA warning-letter register
No letter on file for this provider

What we like

  • Review page kept live so former patients get a straight answer

Watch-outs

  • Website does not load, so there is no way to sign up or reorder
  • No published notice explains the outage or where patients should go

Is Curve still an option?

Curve no longer offers a GLP-1 weight-loss program, so there is nothing to sign up for today. We cannot quote a current price, because none exists. We keep this page online so past users can see what it offered and find a program that still operates.

If you were a Curve patient, talk with your prescriber before your remaining supply runs out. That keeps treatment going without a gap or an unsafe restart dose. Then compare current providers on price, medication and state coverage, starting with the alternatives below.

The Bottom Line

Curve scores highest on state availability and ease of access.

Score: 7.2/10Best for: former Curve patients looking for a current GLP-1 provider

Curve might not be your best fit if…

We rank editorially, so here’s where a different provider we track may serve you better.

  • If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider altRX.
  • If you want built-in coaching and behavior-change support, consider Found.
See all alternatives to Curve →

Frequently Asked Questions

Not that anyone can reach. trycurve.co no longer loads: the secure address fails before a page is served and the plain address returns a hosting error, and that has held across repeated checks on different days. Curve has published no closure notice or new address, so there is no working way to start or continue a program.
Talk with a prescriber before your current supply runs out, so treatment continues without a gap or an unsafe restart dose. If your medication label names a pharmacy, keep that information, because the dispensing pharmacy is a separate business. Then compare current providers on price, medication and state coverage.
People still search for Curve, and a clear answer beats a dead link. This page is excluded from every ranking on this site, carries no outbound link to the old service, and points to currently operating alternatives instead.
Yes — Curve is a legitimate telehealth provider. Our editors independently verified its pricing and offering and scored it 7.2/10. As with any medication, consult a licensed clinician before starting.
We don't find any safety warnings on file (no FDA action). The concerns our review flags are mostly transparency-related: Website does not load, so there is no way to sign up or reorder; No published notice explains the outage or where patients should go. None are safety issues, but they're worth weighing before you sign up.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Sources

The primary regulatory filings and peer-reviewed studies cited throughout this Curve review:

Sources & methodology — as of October 2026
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
  2. 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  3. 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
  4. 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
  5. 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.